Nadir Mahmood Ph.D.
Net Worth

Last updated:

What is Nadir Mahmood Ph.D. net worth?

The estimated net worth of Dr. Nadir Mahmood Ph.D. is at least $3,524,597 as of 20 Jun 2023. He owns shares worth $200,716 as insider, has earned $927,981 from insider trading and has received compensation worth at least $2,395,900 in Nkarta, Inc..

What is the salary of Nadir Mahmood Ph.D.?

Dr. Nadir Mahmood Ph.D. salary is $479,180 per year as Chief Financial & Bus. Officer in Nkarta, Inc..

How old is Nadir Mahmood Ph.D.?

Dr. Nadir Mahmood Ph.D. is 46 years old, born in 1979.

What stocks does Nadir Mahmood Ph.D. currently own?

As insider, Dr. Nadir Mahmood Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Nkarta, Inc. (NKTX) Chief Financial & Bus. Officer 85,776 $2.34 $200,716

What does Nkarta, Inc. do?

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

NKTX logo
NKTX
Nkarta, Inc.
$2.34

Nadir Mahmood Ph.D. insider trading

Nkarta, Inc.

Dr. Nadir Mahmood Ph.D. has made 9 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 526 units of NKTX stock worth $2,551 on 20 Jun 2023.

The largest trade he's ever made was exercising 7,500 units of NKTX stock on 25 Jul 2022. As of 20 Jun 2023 he still owns at least 85,776 units of NKTX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 526 $4.85 $2,551
Sale
Common Stock 1,122 $5.49 $6,160
Option
Stock Option (right to buy) 4,819 $3.89 $18,746
Option
Common Stock 7,500 $3.89 $29,175
Option
Stock Option (right to buy) 2,681 $3.89 $10,429
Sale
Common Stock 7,500 $18.03 $135,218
Option
Common Stock 7,500 $3.89 $29,175
Option
Stock Option (right to buy) 7,500 $3.89 $29,175
Sale
Common Stock 7,500 $15.32 $114,900
Sale
Common Stock 7,500 $13.4 $100,478
Option
Stock Option (right to buy) 7,500 $3.89 $29,175
Option
Common Stock 7,500 $3.89 $29,175
Option
Common Stock 3,500 $3.89 $13,615
Sale
Common Stock 6,500 $31.71 $206,115
Option
Stock Option (right to buy) 3,500 $3.89 $13,615
Option
Common Stock 1,800 $3.89 $7,002
Option
Stock Option (right to buy) 1,800 $3.89 $7,002
Sale
Common Stock 3,000 $27.16 $81,480
Option
Stock Option (right to buy) 3,500 $3.89 $13,615
Option
Common Stock 3,500 $3.89 $13,615
Sale
Common Stock 3,500 $3.89 $13,615
Option
Stock Option (right to buy) 5,500 $3.89 $21,395
Option
Common Stock 5,500 $3.89 $21,395
Sale
Common Stock 5,500 $48.63 $267,465
Option
Stock Option (right to buy) 3,083 $3.89 $11,993
Option
Common Stock 3,083 $3.89 $11,993
Option
Stock Option (right to buy) 3,000 $3.89 $11,670
Option
Common Stock 3,000 $3.89 $11,670

Nkarta key executives

Nkarta, Inc. executives and other stock owners filed with the SEC: